1FJ1 image
Deposition Date 2000-08-07
Release Date 2000-10-11
Last Version Date 2024-11-13
Entry Detail
PDB ID:
1FJ1
Keywords:
Title:
LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.68 Å
R-Value Free:
0.28
R-Value Work:
0.22
Space Group:
P 21 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:HYBRIDOMA ANTIBODY LA2 (LIGHT CHAIN)
Chain IDs:A, C
Chain Length:213
Number of Molecules:2
Biological Source:Mus musculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:HYBRIDOMA ANTIBODY LA2 (HEAVY CHAIN)
Chain IDs:B, D
Chain Length:213
Number of Molecules:2
Biological Source:Mus musculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:OUTER SURFACE PROTEIN A
Chain IDs:E, F
Chain Length:257
Number of Molecules:2
Biological Source:Borrelia burgdorferi
Primary Citation
Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
J.Mol.Biol. 302 1153 1164 (2000)
PMID: 11183781 DOI: 10.1006/jmbi.2000.4119

Abstact

Outer surface protein A (OspA) is a major lipoprotein of the Borrelia burgdorferi spirochete, the causative agent of Lyme disease. Vaccination with OspA generates an immune response that can prevent bacterial transmission to a mammalian host during the attachment of an infected tick. However, the protective capacity of immune sera cannot be predicted by measuring total anti-OspA antibody. The murine monoclonal antibody LA-2 defines an important protective B-cell epitope of OspA against which protective sera have strong levels of reactivity. We have now mapped the LA-2 epitope of OspA using both NMR chemical-shift perturbation measurements in solution and X-ray crystal structure determination. LA-2 recognizes the three surface-exposed loops of the C-terminal domain of OspA that are on the tip of the elongated molecule most distant from the lipid-modified N terminus. The structure suggests that the natural variation at OspA sequence position 208 in the first loop is a major limiting factor for antibody cross-reactivity between different Lyme disease-causing Borrelia strains. The unusual Fab-dominated lattice of the crystal also permits a rare view of antigen flexibility within an antigen:antibody complex. These results provide a rationale for improvements in OspA-based vaccines and suggest possible designs for more direct tests of antibody protective levels in vaccinated individuals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback